Concepedia

Ming-Kang Chang

MC

Statistics

Publications

4

Citations

314

H-Index

4

Active since

1994

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Ming-Kang Chang is an author at Novartis (Switzerland) specializing in cell signaling, wnt signaling in osteogenesis, and bone metabolism.

Publications per year

1994–2014

4

Publications

4

Disruption of Lrp4 function by genetic deletion or pharmacological blockade increases bone mass and serum sclerostin levels

Ming-Kang Chang, Ina Krämer, Thomas Huber et al. · Proceedings of the National Academy of Sciences · 2014 · 123 citations · Full text

Medicine, Molecular Biology, Orthopaedic Surgery +17

Silencing of parathyroid hormone (PTH) receptor 1 in T cells blunts the bone anabolic activity of PTH

Brahmchetna Bedi, Jau‐Yi Li, Hesham A. Tawfeek et al. · Proceedings of the National Academy of Sciences · 2012 · 97 citations · Full text

Medicine, Endocrinology, Molecular Biology +17

Reversing <i>LRP</i> <i>5</i>-Dependent Osteoporosis and <i>SOST</i> Deficiency–Induced Sclerosing Bone Disorders by Altering WNT Signaling Activity

Ming-Kang Chang, Ina Krämer, H. J. Keller et al. · Journal of Bone and Mineral Research · 2013 · 74 citations · Full text

Medicine, Cancer Biology, Molecular Medicine +17

Analysis of gain margins and phase margins of a nonlinear reactor control system

Che-Hsu Chang, Ming-Kang Chang · IEEE Transactions on Nuclear Science · 1994 · 20 citations

Engineering, Systems Engineering, Process Control +16

1–4 of 4